Recent advances in pharmaceutical nanotechnology have enabled the development of nano-particulate medicines with enhanced drug performance. Although the fate of these nano-particles can be macroscopically tracked in the body (e.g. using radio-labeling techniques), there is little information about the sub-cellular scale mechanistic processes underlying the particle-tissue interactions, or how these interactions may correlate with pharmaceutical efficacy. To rationally engineer these nano-particles and thus optimize their performance, these mechanistic interactions must be fully understood.
INTRODUCTION
Nanoparticle drug delivery is an area of medical research that is rapidly expanding to provide novel methods for transporting drugs to target organs. Recent advances in polymer formulations using biocompatible quaternary ammonium palmitoyl glycol chitosan (GCPQ) have resulted in nanoparticles capable of encapsulating hydrophobic drugs for enhanced delivery via IV and oral dosing routes [1] [2] [3] . Determining the toxicity of these nanoparticles is obviously of great importance and the mechanisms by which the nanoparticles interact with the body at the cellular level must be understood in order to intelligently engineer novel nano-medicines and better understand their modes of action.
Nanoparticle uptake mechanisms at the cellular scale are currently determined using techniques such as Confocal Laser Scanning Microscopy (CLSM), which rely on the addition of extrinsic labels such as fluorophores. These fluorophores introduce complications for the analysis of the nanoparticle kinetics, since the labels themselves can alter the biological properties of the nanoparticle. There are additional complications with CLSM such as: photobleaching of the sample and frequently toxic labels. Radio-isotope labelling is an alternative technique, whereby substitutions are made of one or more isotopes of an element within a molecule. For instance, hydrogen atoms can be replaced with deuterium in molecules of interest as it enables detection of the molecule without adversely affecting the system's biochemical interactions within an organism 4 .
This method of deuterium labelling has been used in NMR studies of humans to determine the PK and PD of compounds 5 . Deuterated bonds may also be distinguished against a biological background using spectroscopic analysis 6 . In Raman spectroscopy, the CH 2 stretching mode is located at 2840 cm -1 whereas when hydrogen is replaced with deuterium, the CD 2 stretching mode is located at 2100 cm -1 . Therefore it is possible to detect a deuterated molecule of interest by probing the sample at 2100 cm -1 , which lies within what is referred to as the 'silent region' in biological samples.
With this technique, Raman microscopy studies of human cells have used deuterium-labelled proteins without altering the cells' chemical environment 7 . In Raman spectroscopy, the intensity of laser light scattered from a sample is measured in units of wave numbers (cm -1 ) as a function of the energy shift (Raman shift) with respect to the incident beam. The scattered light's energy is shifted relative to the incident beam as a result of interactions with the sample's Raman-active chemical bonds; the Raman spectrum contains narrow peaks corresponding with particular chemical bonds, therefore giving a unique 'fingerprint'. The number of Raman-active bonds within the sample is directly proportional to intensity of the Raman scattered light, thus allowing straightforward quantitative analysis from the detected signal.
Spontaneous Raman scattering would be a potentially attractive method for obtaining chemically selective information from biological specimens, were it not such a prohibitively weak process. This is illustrated by comparing the typical Raman cross-sections per molecule for Raman scattering, which range from 10-25 to 10-30 cm 2 , with typical crosssections for fluorescence, which range from 10-16 to 10-17 cm 2 . Although increasing the incident laser intensity would theoretically improve the signal-to-noise ratio for spontaneous Raman scattering, in practice this would rapidly cause photo-thermal damage to biological specimens. The limitations of spontaneous Raman scattering can be overcome using the non-linear process, coherent anti-Stokes Raman scattering (CARS). Advancements in ultrafast laser technology have allowed CARS microscopy to be developed as a tool for label-free imaging with chemical specificity by probing the vibrational structure of molecules within the sample volume 8, 9 . CARS is a four-wave mixing process in which a pump beam of frequency w p and a Stokes beam, w s , interact within a sample. By tuning the beat frequency (w p -w s ) to match a Raman active vibrational mode, the excitation fields coherently drive the sample molecules resulting in the generation of a strong anti-Stokes signal at (2w p -w s ). CARS microscopy has many advantages over conventional imaging including: up to several hundred micron depth penetration into biological tissue; intrinsic optical sectioning and high spatial resolution; label-free chemically specific contrast. Of the many applications of CARS microscopy, numerous investigations have focused on directly visualising the trafficking of particles, including that of lipid droplets 10 , gold nanoshells 11 , metal oxides 12 and nano-medicines 13 .
Although CARS is a powerful chemically-specific imaging technique, it is not background-free; in addition to the resonant contribution to the CARS signal, there is also an inherent non-resonant component 9, [14] [15] [16] . In biological specimens, this non-resonant background manifests itself as a substantial CARS signal arising predominantly from the sample's bulk water 15, 16 . Since the anti-Stokes signal is blue-shifted with respect to the incident near infrared excitation wavelengths of the pump and Stokes beams, there is diminished fluorescence contribution to the detected CARS signal. However, the autofluorescence of the sample is not zero; although it is true that at excitation wavelengths longer than 800 nm there is little two-photon pyridine nucleotide (NAD(P)H) fluorescence, the two-photon excitation spectra of lipoamide dehydrogenase (LipDh) and flavin adenine dinucleotide (FAD) actually extend to 1000 nm and have broad peaks around 900 nm which allow for excitation of flavoproteins, the emission from which can be detected even up to 650 nm 17 . Therefore, even when the often-selected CARS excitation wavelengths of 924 nm and 1254 nm are used to excite contrast from the CH 2 stretch, when detecting the anti-Stokes shifted signal at around 731 nm there can still be some background autofluorescence contribution (the magnitude of this will partly depend on the bandwidth of the filter used to isolate the anti-Stokes signal).
It is clear that sample autofluorescence has the potential to limit the sensitivity of CARS when detecting sub-voxel sized nanoparticles against biological backgrounds. The process by which the sample has been processed can affect the levels of fluorescence. For instance, samples that have been fixed using aldehydes (e.g. formaldehyde, gluteraldehyde etc.) tend to exhibit aldehyde-induced fluorescence arising from Schiff bases which form during the reaction of aldehydes and the tissues' proteins, thus creating epsilon amino groups 18 . Additionally, some alcohol-based fixation techniques can strip away lipids from the sample, the effects of which have been discussed for imaging brain tissues with CARS 19 . Samples obtained during tissue biopsies in the operating theatre may be snap-frozen or fixed depending on the protocol in use at the time; therefore, there is a need to determine just what effect, if any, sample preparation has on the ability to detect nanoparticles within tissues using CARS. If CARS microscopy is ever to be used in a clinical setting to determine nanoparticle delivery to human organs (e.g. to assess distribution and toxicity), it is crucial that the effects of sample preparation are determined beforehand.
The ideal drug delivery system would transport the drug to the target site (e.g. the brain) whilst simultaneously avoiding build-up of drug within organs to which the drug is toxic (e.g. the kidneys). The ability to visualize nanoparticles within organs such as the kidneys to confirm that there is no significant cellular uptake of potentially toxic drugs is therefore of critical importance for development of new nanomedicines. In this study we investigated the effect of sample preparation on the ability of CARS microscopy to pin-point deuterated GCPQ nanoparticles in kidneys that were either fixed using formaldehyde-based fixative or snap frozen using liquid nitrogen.
METHODS

Spontaneous Raman scattering spectroscopy
Raman spectra were acquired using a Renishaw RM1000 Raman microscope (Renishaw, Wotton-Under-Edge, UK) equipped with a 1200-line/mm grating providing a spectral resolution of 1 cm -1 and a diode laser providing excitation at 785 nm with up to 300 mW power. The system was calibrated using the Raman band of a silicon wafer at 520 cm -1 . Spectral data was acquired using Renishaw v.1.2 WiRE software.
Coherent Anti-Stokes Raman scattering microscopy
Coherent Anti-Stokes Raman Scattering (CARS) microscopy was performed using a custom built imaging system based on a modified commercial confocal laser scanning microscopy and a synchronised dual-wavelength picosecond laser source, as shown in the schematic diagram in figure 1. Laser excitation was provided by an optical parametric oscillator (OPO) (Levante Emerald, APE, Berlin) pumped with a frequency doubled Nd:Vandium picosecond oscillator (High-Q Laser Production GmbH). The pump laser generated a 6 ps, 76 MHz pulse train at 532 nm with adjustable output power up to 10 W. The OPO produced collinear signal and idler beams with perfect temporal overlap and provided continuous tuning over a range of wavelengths. The signal beam was used as the pump, ranging from 670 to 980 nm and the pump laser was used as the Stokes beam at 1064 nm. The maximum combined output power of the signal and idler was approximately 2 W and average power at the sample was between 15 mW and 30 mW. Imaging was performed using a modified inverted microscope and confocal laser scanner (IX71 and FV300, Olympus UK). A schematic of the optical setup is shown in Figure 1 . To maximise IR transmission the standard galvanometer scanning mirrors were replaced with silver galvanometric mirrors, the tube lens was replaced with an MgF2 coated lens and the confocal dichroic was replaced by a silver mirror with high reflectivity throughout the visible and NIR (21010, Chroma Technologies, USA). A 60X, 1.2 NA water immersion objective (UPlanS Apo, Olympus UK) was used.
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The CARS signals were collected using the objective lens in the epi-direction. The epi-CARS signal was separated from the pump and Stokes beams by a long-wave pass dichroic mirror (z850rdc-xr, Chroma Technologies, USA) and directed onto a R3896 photomultiplier tube at the rear microscope port. The anti-Stokes signal was isolated by a single band-pass filter centered at 750 nm (HQ750/ 210, Chroma Technologies USA
Sample preparation -deuterated GCPQ
Acid degradation of glycol chitosan was performed using previously described techniques .
Sample preparation -tissues
All experiments were performed under a UK Home Office Animal License. CD-1 mice were fasted overnight and then administered dGCPQ formulations by oral gavage at the concentration of 1 mg mL -1 . Mice were sacrificed at 4 hours and the kidneys were harvested. Tissues were either snap frozen or stored in neutral buffered formalin (10 % v/v, 15 mL). Harvested kidneys were placed in a matrix (Zivic instruments) and cut in coronal slices of 0.5 mm thickness using cleaned razor blades. Each sample slice was placed onto a cleaned coverslip and placed within a window cut into four layers of Parafilm, which acted as a spacer, upon which a second coverslip was placed. A localised heat source was used to warm the edges of the Parafilm spacer to its melting point of 60 °C, forming a watertight seal and preventing the samples from becoming desiccated.
RESULTS AND DISCUSSION
The spontaneous Raman scattering spectral profile of dGCPQ particles from 1900 cm -1 to 3200 cm -1 was acquired using Renishaw v.1.2 WiRE software and baseline subtracted using Origin 7, as shown in figure 2. Since the palmitoyl chain is the only region of the GCPQ molecule whose CH bonds are substituted for CD bonds, there is still a strong CH-stretch exhibited from ~2750 cm -1 -3050 cm -1 . The CD stretch peak ranges from ~ 2100 cm -1 -2250 cm -1 with the maximum peak height at ~2105 cm -1 . The corresponding CARS peak position for the CD stretch was located at 2100 cm -1 . Successive epi-detected CARS image stacks were acquired of kidney samples using pump and Stokes wavelengths tuned to probe the resonance at 2100 cm -1 (to elicit contrast from the dGCPQ particles) and at 2848 cm -1 (to elicit contrast from endogenous CH-rich structures in the sample, such as lipid droplets and cell membranes). The intensities of the pump and Stokes beams were monitored separately and each beam was attenuated to ensure the same power output when Pixel Greyscale Value 1200 1400 1600
imaging using either 2100 cm -1 or 2845 cm -1 contrast. The total power at the sample was kept at 30 mW, which was sufficiently low to prevent sample damage. Each x-y-z-image stack measured 171 μm x 171 μm x 150 μm with z-step increments of 1 μm; each frame was acquired with a resolution of 256 x 256 pixels and a frame rate of 10 seconds. Using ImageJ software, the surface of the tissue within each sample stack was ascertained, and the signal intensity for the preceding 70 microns of tissue was determined for each channel (CD and CH). The results for these experiments are shown in the graphs in figure 3 . Figure 3 . Epi-detected CARS signal intensity from fixed and unfixed kidney samples (black circle and grey square data points, respectively), obtained with pump and Stokes wavelengths tuned to probe the CH-stretch at 2845 cm -1 (left) and CD-stretch at 2100 cm -1 (right).
The signal output from the microscope is 12-bit depth, thus the greyscale intensity values range from 0 -4095. Since only <1 % of the detected signal was above the greyscale value of 1600, the graphs in figure 2 have been cropped for ease of comparison. At the CH resonance, for the unfixed kidney tissue, the mean greyscale value was 528 with a standard deviation of 187, whereas for the fixed kidney tissue this was 583 with a standard deviation of 236. At the CD resonance, for the unfixed kidney tissue the mean greyscale value was 96 with a standard deviation of 51, whereas for the fixed kidney tissue this was 133 with a standard deviation of 74. For the CD resonance, deuterated GCPQ signal was typically found to exhibit pixel greyscale values of greater than 1600. For fixed kidneys, when imaging at the CH stretch approximately 8.7 % of the pixels exhibited CARS signal that was at a higher grey scale value than for snap-frozen kidneys, whereas when imaging at the CD stretch this figure increased to 25 %. Therefore, fixation-induced autofluorescence clearly has a greater impact on the detected CARS signal when imaging away from the CH resonance and further into the silent region. The increased background signal due to fixationinduced autofluorescence was not sufficiently great as to impede identification of resonant CD signal at 2100 cm -1 , since the resonant signals yielded pixel greyscale values of greater than 1600 and the non-resonant background signal was below this threshold. The brightness and contrast of these images have not been adjusted. The nanoparticles were detected within the kidney tubule spaces, with no dGCPQ signal associated within cell bodies. This finding correlates well with previous work, which found that dGCPQ were excreted in the urine after oral administration 2 . Figure 6 . Epi-detected CARS images of an unfixed kidney sample, harvested after oral dosing with DGCPQ nanoparticles. Left = CH resonance, imaged using pump and Stokes wavelengths tuned to 2848 cm -1 ; right = CD resonance, imaged using pump and Stokes wavelengths tuned to 2100 cm -1 . White arrows indicate the position of dGCPQ particles. Scale bar is 50 microns.
I mw. Figure 7 . Epi-detected CARS images of an unfixed kidney sample, harvested after oral dosing with DGCPQ nanoparticles. Scale bar is 10 microns.
Since the pixel size is larger than the size of a single dGCPQ nanoparticle (~660 nm x 660 nm pixel size, c.f. average dGCPQ particle size of ~200 nm), a single pixel exhibiting dGCPQ signal does not necessarily correlate with a single nanoparticle. We discovered that the dGCPQ signal within the kidney tubules tended to be clustered in regions approximately 1 -8 microns in size, co-localised with strong CH signal.
CONCLUSIONS
We have shown that CARS microscopy is a robust tool that is capable of identifying deuterated GCPQ nanoparticles in both snap-frozen tissues and in tissues exhibiting fixative-induced autofluorescence. Although the non-resonant background levels of signal detected from fixed kidney sections was greater than for snap-frozen kidney sections, this signal level was several of orders of magnitude lower than that associated with the deuterated GCPQ resonant signal when imaging at the CD resonance at 2100 cm -1 . Therefore, it was possible to simply and effectively screen out the nonresonant detected signal using image thresholding. However, our results indicate that when imaging nanoparticles exhibiting a weaker signal, the effects of fluorescence could have a greater negative impact on the detection sensitivity, therefore it is advisable to use snap frozen tissues where possible in such cases.
